Edesa News and Events
News Releases
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
August 8, 2025
Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results
May 14, 2025
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
April 28, 2025
Edesa Biotech Announces Chief Financial Officer Transition
April 4, 2025
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
February 14, 2025
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market
February 13, 2025
Edesa Biotech Reports Fiscal Year 2024 Results
December 13, 2024
Edesa Biotech’s Founder Makes Strategic Investment in the Company
October 31, 2024
Edesa Biotech Announces Upcoming Conference Schedule
October 21, 2024
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
August 09, 2024
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
June 24, 2024
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
May 10, 2024
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
April 11, 2024
Edesa Biotech to Participate in Upcoming Investor Conferences
April 2, 2024
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
March 21, 2024
Edesa Biotech to Participate in Barclays Global Healthcare Conference
March 7, 2024
Edesa Biotech to Participate in Upcoming Dermatology Meetings
March 4, 2024
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
February 9, 2024
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
January 4, 2024